A clinicopathologic study of 100 cases of Parkinson's disease.

The clinical details of 100 cases of histologically confirmed Parkinson's disease were examined and correlated with pathologic findings. Age at disease onset (mean, 62.4 years), disease duration (mean, 13.1 years), and age at death (mean, 75.5 years) were similar to those in previous smaller series. Asymmetric, tremulous onset was most common, although 23% of patients had no rest tremor. Motor fluctuations and dyskinesias occurred in 60% of levodopa-treated patients. All patients had clinical parkinsonism; however, 12 had atypical clinical features of Parkinson's disease, including severe early dementia, fluctuating confusional states, no response to levodopa, and early marked autonomic disturbance. Neuropathologic examination found coexistent Alzheimer-type change in 17 cases and striatal abnormality--mainly vascular--in 34 cases. Cortical Lewy bodies were present in all cases, but only four satisfied proposed criteria for diffuse Lewy body disease. Dementia occurred in 44% of cases; 29% had Alzheimer's disease, 10% had numerous cortical Lewy bodies, and 6% had a possible vascular cause; in 55% no definite pathologic cause was found. Nigral cell loss correlated with disease duration and severity. Although the general pattern of disease conformed to traditional descriptions, the findings broaden the present clinical and pathologic spectrum of Parkinson's disease.

[1]  S. Roy,et al.  Parkinson's disease in a Scottish city. , 1986, British medical journal.

[2]  Lewy bodies in tyrosine hydroxylase-synthesizing neurons of the human cerebral cortex , 1989, Neuroscience Letters.

[3]  J. Woodard CONCENTRIC HYALINE INCLUSION BODY FORMATION IN MENTAL DISEASE ANALYSIS OF TWENTY‐SEVEN CASES , 1962, Journal of neuropathology and experimental neurology.

[4]  W. Gibb,et al.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[5]  A. Walters,et al.  Clinically atypical expression of pathologically typical Lewy-body parkinsonism. , 1990, Clinical neuropharmacology.

[6]  A. J. Lees,et al.  Neuropathological features of Alzheimer's disease in non-demented parkinsonian patients. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[7]  C. Markham,et al.  Long‐term follow‐up of early dopa treatment in Parkinson's disease , 1986, Annals of neurology.

[8]  E K Perry,et al.  Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia. , 1990, Advances in neurology.

[9]  S. Mirra,et al.  Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients , 1987, Neurology.

[10]  J. Jankovic,et al.  Low cancer rates among patients with Parkinson's disease , 1985, Annals of neurology.

[11]  W. Gibb,et al.  Dementia and Parkinson's Disease , 1989, British Journal of Psychiatry.

[12]  A. Lees PARKINSON'S DISEASE AND DEMENTIA , 1985, The Lancet.

[13]  R. Strang THE OCCURRENCE OF PEPTIC ULCERATION IN PATIENTS WITH PARKINSONISM , 1966 .

[14]  C. Marsden,et al.  Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy , 1990, Neurology.

[15]  Forno Ls,et al.  The pathology of Parkinsonism: a comparison of degenerations in cerebral cortex and brainstem. , 1974 .

[16]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[17]  M. Drazner,et al.  Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors? , 1989, Archives of neurology.

[18]  H. Braak,et al.  Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles, and neuropil threads in the cerebral cortex , 1990, Journal of neural transmission. Parkinson's disease and dementia section.

[19]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[20]  D. Knopman,et al.  Dementia lacking distinctive histologie features , 1990, Neurology.

[21]  E. Perry,et al.  CLINICALLY AND NEUROPATHOLOGICALLY DISTINCT FORM OF DEMENTIA IN THE ELDERLY , 1989, The Lancet.

[22]  M. Muenter,et al.  Multi‐center study of Parkinson mortality with early versus later dopa treatment , 1987, Annals of neurology.

[23]  C. Markham,et al.  An examination of male‐female differences in progression and mortality of Parkinson's disease , 1990, Neurology.

[24]  J. Jankovic,et al.  The heterogeneity of Parkinson's disease , 1985, Neurology.

[25]  C. Marsden,et al.  HOW COMMON IS DEMENTIA IN PARKINSON'S DISEASE? , 1984, The Lancet.

[26]  C. Marsden,et al.  Dementia and Parkinson's disease--pathological and neurochemical considerations. , 1986, British medical bulletin.

[27]  R. Godwin-Austen,et al.  Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[28]  W. Gibb Cortical lewy body dementia. , 1990, Behavioural neurology.

[29]  W. Gibb,et al.  A comparison of clinical and pathological features of young‐ and old‐onset Parkinson's disease , 1988, Neurology.

[30]  D. Selkoe,et al.  Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases , 1988, Annals of neurology.

[31]  Parkinsonism treated with levodopa: progression and mortality. , 1983 .

[32]  K. Jellinger,et al.  New developments in the pathology of Parkinson's disease. , 1990, Advances in neurology.

[33]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[34]  W. Gibb,et al.  THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE , 1989, Neuropathology and applied neurobiology.

[35]  J. Kurtzke,et al.  The changing patterns of death rates in parkinsonism , 1990, Neurology.

[36]  Z. Khachaturian Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[37]  M. Musicco,et al.  The occurrence of motor fluctuations in parkinsonian patients treated long term with levodopa , 1991, Neurology.

[38]  R. Marttila,et al.  DEMENTIA IN PARKINSON'S DISEASE , 1976, Acta neurologica Scandinavica.

[39]  L. Thal,et al.  The Lewy body variant of Alzheimer's disease , 1990, Neurology.

[40]  P. Mölsä,et al.  Extrapyramidal signs in Alzheimer's disease , 1984, Neurology.

[41]  F. Mcdowell,et al.  “Early” initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease , 1991, Neurology.

[42]  J. Parkinson An Essay on the Shaking Palsy , 2002 .